| Sym | Weight | Trade Impact | Company | Class | Share Change | Activity | Value Change $ | Value $ | * Price $ | Shares | Principal |
|---|
Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)
| Name | Title | City, State | Date |
|---|---|---|---|
| Matthew Okkerse | CFO | Milford, Michigan | 13 Nov 2025 |
The information included on the Information Table with respect to the holdings of Femasys Inc. ("FEMA") and Kazia Therapeutics Limited ("KZIA") reflect the exercise of Pre-funded Warrants held by Dauntless Investment Group, LLC ("DIG") after giving effect to provisions that prevent the exercise of such securities if the beneficial ownership of such entity would exceed 9.99% of the underlying security following such exercise. As of September 30, 2025, DIG held an aggregate of 4,395,996 Common Shares of FEMA and 176,822 American Depository Shares of KZIA.